Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
84.34
-1.20 (-1.40%)
At close: Jun 6, 2025, 4:00 PM
83.00
-1.34 (-1.59%)
After-hours: Jun 6, 2025, 6:15 PM EDT
Verona Pharma Market Cap
Verona Pharma has a market cap or net worth of $7.69 billion as of June 6, 2025. Its market cap has increased by 658.46% in one year.
Market Cap
7.69B
Enterprise Value
7.53B
1-Year Change
658.46%
Ranking
Category
Stock Price
$84.34
Market Cap Chart
Since April 27, 2017, Verona Pharma's market cap has increased from $173.40M to $7.69B, an increase of 4,333.11%. That is a compound annual growth rate of 59.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 7.18B | 88.94% |
| Dec 31, 2024 | 3.80B | 139.13% |
| Dec 29, 2023 | 1.59B | -19.57% |
| Dec 30, 2022 | 1.98B | 389.96% |
| Dec 31, 2021 | 403.30M | 33.68% |
| Dec 31, 2020 | 301.70M | 298.55% |
| Dec 31, 2019 | 75.70M | -40.25% |
| Dec 31, 2018 | 126.70M | -16.92% |
| Dec 29, 2017 | 152.50M | -12.05% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.52B |
| Johnson & Johnson | 368.66B |
| AbbVie | 330.92B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 272.49B |
| Abbott Laboratories | 231.33B |
| Novartis AG | 229.87B |
| AstraZeneca | 226.47B |